RADL3 Stock Overview
Engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
Raia Drogasil S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R$22.32 |
| 52 Week High | R$30.40 |
| 52 Week Low | R$22.32 |
| Beta | 0.32 |
| 1 Month Change | -13.12% |
| 3 Month Change | -18.57% |
| 1 Year Change | -22.18% |
| 3 Year Change | -3.60% |
| 5 Year Change | 7.11% |
| Change since IPO | 3,297.00% |
Recent News & Updates
Raia Drogasil S.A.'s (BVMF:RADL3) Price In Tune With Earnings
Nov 26
Earnings Beat: Raia Drogasil S.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Nov 08Raia Drogasil (BVMF:RADL3) Has A Pretty Healthy Balance Sheet
Oct 13Recent updates
Raia Drogasil S.A.'s (BVMF:RADL3) Price In Tune With Earnings
Nov 26Earnings Beat: Raia Drogasil S.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Nov 08Raia Drogasil (BVMF:RADL3) Has A Pretty Healthy Balance Sheet
Oct 13Returns Are Gaining Momentum At Raia Drogasil (BVMF:RADL3)
Sep 25Raia Drogasil S.A. Just Missed Earnings - But Analysts Have Updated Their Models
Aug 10With Raia Drogasil S.A. (BVMF:RADL3) It Looks Like You'll Get What You Pay For
Jul 13Raia Drogasil (BVMF:RADL3) Seems To Use Debt Quite Sensibly
Apr 08Does Raia Drogasil (BVMF:RADL3) Deserve A Spot On Your Watchlist?
Mar 24Investors Met With Slowing Returns on Capital At Raia Drogasil (BVMF:RADL3)
Jan 29Raia Drogasil S.A.'s (BVMF:RADL3) Earnings Haven't Escaped The Attention Of Investors
Dec 29Shareholder Returns
| RADL3 | BR Consumer Retailing | BR Market | |
|---|---|---|---|
| 7D | -11.4% | -13.1% | -7.2% |
| 1Y | -22.2% | -33.7% | -11.5% |
Return vs Industry: RADL3 exceeded the BR Consumer Retailing industry which returned -29.6% over the past year.
Return vs Market: RADL3 underperformed the BR Market which returned -9.2% over the past year.
Price Volatility
| RADL3 volatility | |
|---|---|
| RADL3 Average Weekly Movement | 4.3% |
| Consumer Retailing Industry Average Movement | 7.1% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in BR Market | 9.2% |
| 10% least volatile stocks in BR Market | 2.7% |
Stable Share Price: RADL3 has not had significant price volatility in the past 3 months compared to the BR market.
Volatility Over Time: RADL3's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1905 | 62,402 | Marcílio Pousada | rdsaude.com.br |
Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. It sells its products through stores, telesales, and call centers in the states of São Paulo, Tocantins, and Pernambuco. The company was founded in 1905 and is headquartered in São Paulo, Brazil.
Raia Drogasil S.A. Fundamentals Summary
| RADL3 fundamental statistics | |
|---|---|
| Market cap | R$40.92b |
| Earnings (TTM) | R$1.11b |
| Revenue (TTM) | R$37.70b |
34.5x
P/E Ratio1.0x
P/S RatioIs RADL3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RADL3 income statement (TTM) | |
|---|---|
| Revenue | R$37.70b |
| Cost of Revenue | R$26.45b |
| Gross Profit | R$11.25b |
| Other Expenses | R$10.14b |
| Earnings | R$1.11b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.65 |
| Gross Margin | 29.83% |
| Net Profit Margin | 2.95% |
| Debt/Equity Ratio | 51.8% |
How did RADL3 perform over the long term?
See historical performance and comparisonDividends
0.9%
Current Dividend Yield51%
Payout RatioDoes RADL3 pay a reliable dividends?
See RADL3 dividend history and benchmarks| Raia Drogasil dividend dates | |
|---|---|
| Ex Dividend Date | Oct 04 2024 |
| Dividend Pay Date | May 30 2025 |
| Days until Ex dividend | 76 days |
| Days until Dividend pay date | 162 days |
Does RADL3 pay a reliable dividends?
See RADL3 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 06:26 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Raia Drogasil S.A. is covered by 30 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Georgia Jorge | BB Banco de Investimento S.A. |
| Robert Ford Aguilar | BofA Global Research |
| Marcio Osako | Bradesco S.A. Corretora de Títulos e Valores Mobiliários |